CARPEUS : Effect of Carvedilol on the Portosystemic Gradient as Measured by Endoscopic Ultrasound

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 16, 2025

Primary Completion Date

March 1, 2028

Study Completion Date

April 1, 2028

Conditions
CirrhosisPortal Hypertension Related to Cirrhosis
Interventions
DRUG

Carvedilol

"Carvedilol per os, day 1:3.125 mg once, day 2 to day 8: 6.25 mg/day (3.125 mg twice a day), day 9 to day 90 (end of study visit): 12.5 mg/day (6.25 mg twice a day).~After the end of the study, treatment with Carvedilol will be prescribed by a cardiologist and continued at the dose of 12.5 mg/day.~The follow-up of the patient will be then done according to the standard practice."

Trial Locations (2)

63000

NOT_YET_RECRUITING

Lise Laclautre, Clermont-Ferrand

63003

RECRUITING

Chu Estaing Medecine Digestive Et Hepatobiliaire, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER